Items are mission critical: reagents are required to pre-screen blood products for donation.
Ended Awarded Last action
- Contract number
- HT009026FG1230013
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $49,194
Award facts
- Contract value 100% obligated
- $49,193.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Chicago, IL 60064, USA
Award details come from SAM.gov/FPDS.
About this award
Abbott Laboratories Inc.'s Abbott Diagnostics Division has been awarded a $49,193.64 firm fixed-price blanket purchase agreement (BPA) call by the Defense Health Agency on November 27, 2025, with a completion date of September 30, 2026. The contract covers mission-critical reagents required to pre-screen blood products for donation, supporting essential military blood banking operations. The work will be performed in North Chicago, Illinois. This award was made without any set-aside designation, reflecting Abbott's competitive positioning in the unrestricted federal healthcare marketplace.
This BPA call is issued under Abbott's larger master contract vehicles established with the Defense Health Agency for immunochemistry reagents and blood product screening consumables, which collectively exceed $4 million. Abbott Laboratories has established itself as a strategic federal supplier of clinical laboratory diagnostic technologies, holding multiple indefinite delivery vehicles and blanket purchase agreements across the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency networks. The Abbott Diagnostics Division's federal contract footprint demonstrates sustained government demand for the company's advanced laboratory analyzers, reagents, and specialized diagnostic solutions that enable comprehensive patient testing across military and veteran healthcare systems.
Quick answers
Who was awarded contract HT009026FG1230013?
HT009026FG1230013 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on November 27, 2025.
How much is contract HT009026FG1230013 worth?
The government has obligated $49,194 on HT009026FG1230013.
Is contract HT009026FG1230013 an order under another contract?
Yes. HT009026FG1230013 is a BPA call under FA301624A0044, a blanket purchase agreement.
Was contract HT009026FG1230013 competed?
The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award